47 results on '"Björk, Elisabeth"'
Search Results
2. Production of fines from refined kraft pulp by fractionation with micro-perforated screens
3. Use of fines-enriched chemical pulp to increase CTMP strength
4. Production of fines from refined kraft pulp by fractionation with micro-perforated screens
5. Some key aspects on screening of chemical pulp to achieve a fine fraction – a literature review
6. Production and application of fine fractions made of chemical pulp for enhanced paperboard strength
7. Production of a fine fraction using micro-perforated screens
8. Production of a fine fraction of refined kraft pulp using micro-perforated screens
9. Production of a fine fraction using micro-perforated screens
10. Temporary Preservation of β-Cell Function by Diazoxide Treatment in Childhood Type 1 Diabetes
11. Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
12. The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
13. Family Characteristics and Life Events Before the Onset of Autoimmune Type 1 Diabetes in Young Adults: A nationwide study
14. KATP Channel Openers Protect Rat Islets Against the Toxic Effect of Streptozotocin
15. PCR Analysis as a Method of Microbiological Control in Endodontic Treatment Is there a Correlation to Healing? A pilot study
16. Fines-enriched pulp as a strength agent in a CTMP middle ply
17. Production of pulps with an extremely high fines content for use as strength agent
18. Usage of Fines-Enriched Pulp to Increase Strength in CTMP
19. Single-stage hydrocyclone fractionation of refined bleached softwood pulp
20. Flow imaging characterisation of morphological changes of chemical pulp due to refining
21. Flow imaging characterisation of morphological changes of chemical pulp due to refining
22. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults
23. Models for plasma glucose, HbA1c, and hemoglobin interrelationships in patients with type 2 diabetes following tesaglitazar treatment
24. Blood glucose in acute stroke, different therapeutic targets for diabetic and non-diabetic patients?
25. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes
26. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.
27. Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults : a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden
28. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.
29. The incidence of Type 1 diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998
30. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
31. Factors predicting clinical remission in adult patients with type 1 diabetes
32. CRP and IL-6 concentrations are associated with poor glycemic control despite preservedβ-cell function during the first year after diagnosis of type 1 diabetes
33. Beta-cell Activity and Destruction in Type 1 Diabetes
34. Experimental studies on autoantigen regulation in insulin-dependent diabetes mellitus
35. Induction of β-Cell Rest in Type 1 Diabetes: Studies on the effects of octreotide and diazoxide
36. Beta-Cell Rest: A Strategy for the Prevention of Autoimmune Diabetes
37. GAD Autoantibodies in IDDM, Stiff-Man Syndrome, and Autoimmune Polyendocrine Syndrome Type I Recognize Different Epitopes
38. Modulation of Beta-Cell Activity and its Influence on Islet Cell Antibody (ICA) and Islet Cell Surface Antibody (ICSA) Reactivity
39. Temporary Preservation of β-Cell Function byDiazoxide Treatment in Childhood Type 1 Diabetes.
40. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.
41. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved β-cell function during the first year after diagnosis of type 1 diabetes.
42. High-glucose stimulation of 64,000-Mr islet cell autoantigen expression.
43. CRP and IL-6 concentrations are associated with poor glycaemic control despite preserved β-cell function during the first year after diagnosis of type 1 diabetes.
44. Remaning β-cell function eight years after diagnosis of autoimmune diabetes in young adults. : Relation to islet antibodies and clinical features
45. Characterization of morphological changes of chemical pulp fibres and fines due to refining
46. Electrochemical Characteristics of Lignin in CTMP for Paper Battery Electrodes.
47. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.